Wen Jian Tang

511 total citations
10 papers, 445 citations indexed

About

Wen Jian Tang is a scholar working on Molecular Biology, Organic Chemistry and Toxicology. According to data from OpenAlex, Wen Jian Tang has authored 10 papers receiving a total of 445 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Organic Chemistry and 4 papers in Toxicology. Recurrent topics in Wen Jian Tang's work include Bioactive Compounds and Antitumor Agents (4 papers), Synthesis and biological activity (4 papers) and Telomeres, Telomerase, and Senescence (3 papers). Wen Jian Tang is often cited by papers focused on Bioactive Compounds and Antitumor Agents (4 papers), Synthesis and biological activity (4 papers) and Telomeres, Telomerase, and Senescence (3 papers). Wen Jian Tang collaborates with scholars based in China. Wen Jian Tang's co-authors include Xin Hua Liu, Jing Bo Shi, Liu Zeng Chen, Rong Li, Yang Wang, Xiu Cheng, Bo Li, Chen Liao, Jing Shi and Xiaobin Wang and has published in prestigious journals such as Journal of Medicinal Chemistry, European Journal of Medicinal Chemistry and Cell Death and Disease.

In The Last Decade

Wen Jian Tang

10 papers receiving 439 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wen Jian Tang China	9	273	158	70	41	38	10	445
Liu Zeng Chen China	11	192 0.7×	171 1.1×	67 1.0×	24 0.6×	29 0.8×	14	411
Ruo‐Jun Man China	14	266 1.0×	194 1.2×	74 1.1×	35 0.9×	19 0.5×	30	476
Anna‐Maria Katsori Greece	11	182 0.7×	209 1.3×	73 1.0×	18 0.4×	28 0.7×	13	445
Fa-Qian Shen China	9	246 0.9×	139 0.9×	87 1.2×	31 0.8×	22 0.6×	10	403
Laura Piccagli Italy	12	251 0.9×	223 1.4×	54 0.8×	11 0.3×	18 0.5×	12	527
Zhili Zhang China	11	225 0.8×	164 1.0×	46 0.7×	29 0.7×	18 0.5×	40	391
Oya Ünsal Tan Türkiye	15	516 1.9×	162 1.0×	155 2.2×	128 3.1×	35 0.9×	32	687
Artem D. Rogachev Russia	13	101 0.4×	198 1.3×	41 0.6×	23 0.6×	15 0.4×	58	410
Ehab M. Gedawy Egypt	14	405 1.5×	303 1.9×	87 1.2×	43 1.0×	12 0.3×	29	640
Ángel Amesty Spain	13	207 0.8×	197 1.2×	59 0.8×	28 0.7×	8 0.2×	40	464

Countries citing papers authored by Wen Jian Tang

Since Specialization

Citations

This map shows the geographic impact of Wen Jian Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen Jian Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen Jian Tang more than expected).

Fields of papers citing papers by Wen Jian Tang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wen Jian Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen Jian Tang. The network helps show where Wen Jian Tang may publish in the future.

Co-authorship network of co-authors of Wen Jian Tang

This figure shows the co-authorship network connecting the top 25 collaborators of Wen Jian Tang. A scholar is included among the top collaborators of Wen Jian Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wen Jian Tang. Wen Jian Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Shi, Jing Bo, Liu Zeng Chen, Xin Huang, et al.. (2019). Novel Pyrazolo[4,3-d]pyrimidine as Potent and Orally Active Inducible Nitric Oxide Synthase (iNOS) Dimerization Inhibitor with Efficacy in Rheumatoid Arthritis Mouse Model. Journal of Medicinal Chemistry. 62(8). 4013–4031. 34 indexed citations

Wang, Xiaobin, et al.. (2018). Novel curcumin analogue hybrids: Synthesis and anticancer activity. European Journal of Medicinal Chemistry. 156. 493–509. 42 indexed citations

Chen, Liu Zeng, Bo Li, Xiu Cheng, et al.. (2017). New arylpyrazoline-coumarins: Synthesis and anti-inflammatory activity. European Journal of Medicinal Chemistry. 138. 170–181. 118 indexed citations

Cheng, Xiu, Jing Bo Shi, Hao Liu, et al.. (2017). Discovery of (4-bromophenyl)(3-hydroxy-4-methoxyphenyl)methanone through upregulating hTERT induces cell apoptosis and ERS. Cell Death and Disease. 8(8). e3016–e3016. 6 indexed citations

Zhang, Juping, et al.. (2017). New pentadienone oxime ester derivatives: synthesis and anti-inflammatory activity. Journal of Enzyme Inhibition and Medicinal Chemistry. 33(1). 130–138. 23 indexed citations

Tang, Wen Jian, et al.. (2017). Novel benzopyran derivatives and their therapeutic applications: a patent review (2009–2016). Expert Opinion on Therapeutic Patents. 27(9). 1031–1045. 30 indexed citations

Shi, Jing Bo, Liu Zeng Chen, Yang Wang, et al.. (2016). Benzophenone-nucleoside derivatives as telomerase inhibitors: Design, synthesis and anticancer evaluation in vitro and in vivo. European Journal of Medicinal Chemistry. 124. 729–739. 22 indexed citations

Wang, Yang, Fei Cheng, Wen Jian Tang, et al.. (2016). Dihydropyrazole derivatives as telomerase inhibitors: Structure-based design, synthesis, SAR and anticancer evaluation in vitro and in vivo. European Journal of Medicinal Chemistry. 112. 231–251. 48 indexed citations

Chen, Yanyan, et al.. (2016). Novel dihydropyrazole-chromen: Design and modulates hTERT inhibition proliferation of MGC-803. European Journal of Medicinal Chemistry. 110. 65–75. 21 indexed citations

10.

Shi, Jing Bo, et al.. (2014). Novel pyrazole-5-carboxamide and pyrazole–pyrimidine derivatives: Synthesis and anticancer activity. European Journal of Medicinal Chemistry. 90. 889–896. 101 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact